{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:15:02Z","timestamp":1761401702081,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Horserace Betting Levy Board of the United Kingdom"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.nmd.2013.11.009","type":"journal-article","created":{"date-parts":[[2013,11,24]],"date-time":"2013-11-24T09:17:32Z","timestamp":1385284652000},"page":"250-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adenovirus-mediated expression of myogenic differentiation factor 1 (MyoD) in equine and human dermal fibroblasts enables their conversion to caffeine-sensitive myotubes"],"prefix":"10.1016","volume":"24","author":[{"given":"Marta","family":"Fernandez-Fuente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Martin-Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Vassaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Muntoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare M.","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2013.11.009_b0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/vr.155.20.625","article-title":"Prevalence and demographic characteristics of exertional rhabdomyolysis in horses in Australia","volume":"155","author":"Cole","year":"2004","journal-title":"Vet Rec"},{"key":"10.1016\/j.nmd.2013.11.009_b0010","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2460\/ajvr.1999.60.12.1562","article-title":"Epidemiologic analysis of factors influencing exertional rhabdomyolysis in Thoroughbreds","volume":"60","author":"MacLeay","year":"1999","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.nmd.2013.11.009_b0015","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/vr.156.24.763","article-title":"Incidence and risk factors associated with exertional rhabdomyolysis syndrome in National Hunt racehorses in Great Britain","volume":"156","author":"Upjohn","year":"2005","journal-title":"Vet Rec"},{"key":"10.1016\/j.nmd.2013.11.009_b0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2052.2008.01778.x","article-title":"A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses","volume":"40","author":"Herszberg","year":"2009","journal-title":"Anim Genet"},{"issue":"Suppl. 2","key":"10.1016\/j.nmd.2013.11.009_b0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2052.2010.02124.x","article-title":"Estimated prevalence of the type 1 polysaccharide storage myopathy mutation in selected North American and European breeds","volume":"41","author":"McCue","year":"2010","journal-title":"Anim Genet"},{"key":"10.1016\/j.nmd.2013.11.009_b0030","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1939-1676.2008.0167.x","article-title":"Glycogen synthase 1 (GYS1) mutation in diverse breeds with polysaccharide storage myopathy","volume":"22","author":"McCue","year":"2008","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.nmd.2013.11.009_b0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2746\/042516409X407611","article-title":"A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds","volume":"41","author":"Stanley","year":"2009","journal-title":"Equine Vet J"},{"key":"10.1016\/j.nmd.2013.11.009_b0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygeno.2008.01.011","article-title":"Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis","volume":"91","author":"McCue","year":"2008","journal-title":"Genomics"},{"key":"10.1016\/j.nmd.2013.11.009_b0045","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2460\/ajvr.1999.60.08.992","article-title":"Abnormal regulation of muscle contraction in horses with recurrent exertional rhabdomyolysis","volume":"60","author":"Lentz","year":"1999","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.nmd.2013.11.009_b0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0034-5288(93)90019-C","article-title":"Caffeine contractures, twitch characteristics and the threshold for Ca(2+)-induced Ca2+ release in skeletal muscle from horses with chronic intermittent rhabdomyolysis","volume":"54","author":"Beech","year":"1993","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.nmd.2013.11.009_b0055","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2013.11.009_b0060","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group","volume":"56","author":"Temh","year":"1984","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2013.11.009_b0065","doi-asserted-by":"crossref","first-page":"e11594","DOI":"10.1371\/journal.pone.0011594","article-title":"Epidemiology of exertional rhabdomyolysis susceptibility in standardbred horses reveals associated risk factors and underlying enhanced performance","volume":"5","author":"Isgren","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nmd.2013.11.009_b0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1939-1676.2009.0274.x","article-title":"Malignant hyperthermia associated with ryanodine receptor 1 (C7360G) mutation in Quarter Horses","volume":"23","author":"Aleman","year":"2009","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.nmd.2013.11.009_b0075","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1172\/JCI993","article-title":"Intracellular calcium homeostasis in human primary muscle cells from malignant hyperthermia-susceptible and normal individuals. Effect of overexpression of recombinant wild-type and Arg163Cys mutated ryanodine receptors","volume":"101","author":"Censier","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2013.11.009_b0080","doi-asserted-by":"crossref","first-page":"43838","DOI":"10.1074\/jbc.M403612200","article-title":"Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease","volume":"279","author":"Ducreux","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2013.11.009_b0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/bja\/aef237","article-title":"Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells","volume":"89","author":"Girard","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2013.11.009_b0090","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nmd.2004.03.011","article-title":"Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model","volume":"14","author":"Wehner","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2013.11.009_b0095","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0022-510X(91)90309-U","article-title":"Muscle regeneration after imposed injury is better in younger than older mdx dystrophic mice","volume":"104","author":"Zacharias","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2013.11.009_b0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1432-0436.2001.680407.x","article-title":"The skeletal muscle satellite cell: stem cell or son of stem cell?","volume":"68","author":"Zammit","year":"2001","journal-title":"Differentiation"},{"key":"10.1016\/j.nmd.2013.11.009_b0105","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.1073\/pnas.87.20.7988","article-title":"MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes","volume":"87","author":"Choi","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2013.11.009_b0110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2460\/ajvr.69.12.1637","article-title":"Assessment of the transformation of equine skin-derived fibroblasts to multinucleated skeletal myotubes following lentiviral-induced expression of equine myogenic differentiation 1","volume":"69","author":"Fernandez-Fuente","year":"2008","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.nmd.2013.11.009_b0115","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1172\/JCI1505","article-title":"High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies","volume":"101","author":"Lattanzi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2013.11.009_b0120","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1073\/pnas.86.14.5434","article-title":"Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD","volume":"86","author":"Weintraub","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2013.11.009_b0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nmd.2007.01.003","article-title":"Desmin immunolocalisation in autosomal dominant Emery\u2013Dreifuss muscular dystrophy","volume":"17","author":"Piercy","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2013.11.009_b0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.domaniend.2012.01.006","article-title":"Novel diabetes mellitus treatment: mature canine insulin production by canine striated muscle through gene therapy","volume":"43","author":"Niessen","year":"2012","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.nmd.2013.11.009_b0135","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddl221","article-title":"Characterization of recessive RYR1 mutations in core myopathies","volume":"15","author":"Zhou","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2013.11.009_b0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12094-006-0149-y","article-title":"Viral gene therapy","volume":"8","author":"Mancheno-Corvo","year":"2006","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.nmd.2013.11.009_b0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","article-title":"Viral vectors for gene transfer: a review of their use in the treatment of human diseases","volume":"60","author":"Walther","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.nmd.2013.11.009_b0150","doi-asserted-by":"crossref","first-page":"16552","DOI":"10.1073\/pnas.0708145104","article-title":"Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle","volume":"104","author":"Asakura","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2013.11.009_b0155","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2007.03.044","article-title":"Asymmetric self-renewal and commitment of satellite stem cells in muscle","volume":"129","author":"Kuang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nmd.2013.11.009_b0160","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1126\/science.1114758","article-title":"Direct isolation of satellite cells for skeletal muscle regeneration","volume":"309","author":"Montarras","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nmd.2013.11.009_b0165","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmd.2013.11.009_b0170","first-page":"841","article-title":"Caspase-1 as a radio- and chemo-sensitiser in vitro and in vivo","volume":"17","author":"Mart\u00edn-Duque","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.nmd.2013.11.009_b0175","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1242\/dev.01874","article-title":"The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription","volume":"132","author":"Tapscott","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.nmd.2013.11.009_b0180","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/hmg\/10.25.2879","article-title":"Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis","volume":"10","author":"Tilgen","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2013.11.009_b0185","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1074\/jbc.M707353200","article-title":"Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies","volume":"7","author":"Xu","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2013.11.009_b0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archneur.61.1.106","article-title":"Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization","volume":"61","author":"Guis","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nmd.2013.11.009_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/humu.20409","article-title":"Two central core disease (CCD) deletions in the C-terminal region of RYR1 alter muscle excitation-contraction (EC) coupling by distinct mechanisms","volume":"28","author":"Lyfenko","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2013.11.009_b0200","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nmd.2005.06.008","article-title":"Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders","volume":"15","author":"Treves","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2013.11.009_b0205","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/hmg\/ddq506","article-title":"Enhanced excitation-coupled Ca(2+) entry induces nuclear translocation of NFAT and contributes to IL-6 release from myotubes from patients with central core disease","volume":"20","author":"Treves","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2013.11.009_b0210","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.0001-5172.2004.00461.x","article-title":"Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia","volume":"48","author":"Bendahan","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.nmd.2013.11.009_b0215","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","article-title":"Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis","volume":"23","author":"Dlamini","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2013.11.009_b0220","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F","volume":"72","author":"Roelvink","year":"1998","journal-title":"J Virol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613010006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613010006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:02:12Z","timestamp":1760774532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613010006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0960896613010006"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.11.009","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus-mediated expression of myogenic differentiation factor 1 (MyoD) in equine and human dermal fibroblasts enables their conversion to caffeine-sensitive myotubes","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}